U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
168301168301Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of VaterCompletedHas ResultsGastrointestinal CancerDrug: Capecitabine|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00354887
168302168302Investigation Of A New Medication (GW642444) In Asthmatic PatientsCompletedNo Results AvailableAsthmaDrug: GW642444|Drug: Placebo|Drug: salmeterol 50mcghttps://ClinicalTrials.gov/show/NCT00354874
168303168303A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321CompletedNo Results AvailableHealthyBiological: hepatitis B antigen (without alum) plus IMP321|Biological: hepatitis B antigen alone (without alum)|Biological: Engerix Bhttps://ClinicalTrials.gov/show/NCT00354861
168304168304Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaActive, not recruitingNo Results AvailableAdult Malignant Mesenchymoma|Adult Rhabdomyosarcoma|Childhood Alveolar Rhabdomyosarcoma|Childhood Botryoid-Type Embryonal Rhabdomyosarcoma|Childhood Embryonal Rhabdomyosarcoma|Childhood Malignant Mesenchymoma|Non-Metastatic Childhood Soft Tissue Sarcoma|SDrug: Irinotecan Hydrochloride|Biological: Dactinomycin|Drug: Cyclophosphamide|Drug: Vincristine Sulfate|Radiation: Radiation Therapy|Other: Laboratory Biomarker Analysis|Other: Questionnaire Administrationhttps://ClinicalTrials.gov/show/NCT00354835
168305168305Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.TerminatedNo Results AvailableLymphoma, Non-HodgkinDrug: Zevalinhttps://ClinicalTrials.gov/show/NCT00354822
168306168306Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary InsomniaCompletedNo Results AvailableSleep Initiation and Maintenance Disorders|InsomniaDrug: GW679769https://ClinicalTrials.gov/show/NCT00354809
168307168307The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With EnoxaparinRecruitingNo Results AvailableAcute Coronary Syndrome|Venous Thromboembolism|Atrial Fibrillation|Hypercoagulabilityhttps://ClinicalTrials.gov/show/NCT00354796
168308168308Continuity of Leg Movements in VLBW Premature Infants: From Spontaneous Kicking and Supported Stepping to Independent WalkingNot yet recruitingNo Results AvailablePremature Birthhttps://ClinicalTrials.gov/show/NCT00354783
168309168309N-Acetyl Cysteine in TrichotillomaniaCompletedHas ResultsTrichotillomaniaDrug: Placebo|Drug: N-Acetyl Cysteinehttps://ClinicalTrials.gov/show/NCT00354770
168310168310CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor TestingCompletedNo Results AvailableGERDDrug: rabeprazolehttps://ClinicalTrials.gov/show/NCT00354757
168311168311High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or EctomesenchymomaActive, not recruitingHas ResultsSarcomaBiological: dactinomycin|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: ifosfamide|Drug: irinotecan hydrochloride|Drug: vincristine sulfate|Procedure: conventional surgery|Radiation: radiation therapy|Biological: filgrastimhttps://ClinicalTrials.gov/show/NCT00354744
168312168312Efficacy of Pentoxifylline on Primary Nephrotic SyndromeCompletedNo Results AvailableNephrotic SyndromeDrug: pentoxifylline|Drug: Corticosteroidhttps://ClinicalTrials.gov/show/NCT00354731
168313168313Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer PatientsActive, not recruitingNo Results AvailableColon CancerBehavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00354705
168314168314Effect of Two Iron Preparations on Protein in the UrineCompletedNo Results AvailableKidney Failure, Chronic|Anemia, Iron-DeficiencyDrug: Sodium Ferric Gluconate and Iron sucrosehttps://ClinicalTrials.gov/show/NCT00354692
168315168315Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal CancerCompletedNo Results AvailableEsophageal CancerBiological: bevacizumab|Drug: cisplatin|Drug: irinotecan hydrochloride|Genetic: proteomic profiling|Other: diagnostic laboratory biomarker analysis|Other: mass spectrometry|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgery|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00354679
168316168316Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate AsthmaCompletedNo Results AvailableAsthmaDrug: GSK159797https://ClinicalTrials.gov/show/NCT00354666
168317168317A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B AloneActive, not recruitingNo Results AvailableChronic Hepatitis BDrug: LAMIVUDINEhttps://ClinicalTrials.gov/show/NCT00354653
168318168318Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast CancerCompletedHas ResultsBreast CancerDrug: anastrozole|Drug: simvastatin|Other: pharmacological study|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00354640
168319168319The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral DrugsCompletedNo Results AvailableHIV-1Drug: TMC125https://ClinicalTrials.gov/show/NCT00354627
168320168320Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)CompletedNo Results AvailableObstructive Sleep ApneaDevice: ApneaLink Sleep Screenerhttps://ClinicalTrials.gov/show/NCT00354614
168321168321Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity CancerTerminatedHas ResultsFallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity CancerDrug: capecitabine|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00354601
168322168322Arterial Stiffness, Wave Reflections and Renal FailureCompletedNo Results AvailableChronic Renal Failure|Arterial Stiffness|Arterial Wave Reflectionshttps://ClinicalTrials.gov/show/NCT00354588
168323168323Effect of Chinese Herb on Chronic Constipation for Residents in Long-Term Care UnitsCompletedNo Results AvailableChronic ConstipationDrug: Chinese Herb: CCH1https://ClinicalTrials.gov/show/NCT00354575
168324168324A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung CancerTerminatedNo Results AvailableLung Cancer|Non-Small Cell Lung CancerDrug: ABT-751|Drug: Placebo|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00354562
168325168325Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLCCompletedNo Results AvailableLung CancerDrug: bevacizumab + erlotinib hydrochloride|Drug: gemcitabine hydrochloride + cisplatin or carboplatinhttps://ClinicalTrials.gov/show/NCT00354549
168326168326In-patient Study With GSK716155 In Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2|Non-Insulin-Dependent Diabetes MellitusDrug: GSK716155 subcutaneous injections|Biological: placebo injectionhttps://ClinicalTrials.gov/show/NCT00354536
168327168327Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid CarcinomaTerminatedNo Results AvailableSolid Tumor|Thyroid CancerDrug: Capecitabine (Xeloda)|Drug: DTIC-Dome (Dacarbazine)|Drug: Gleevec (Imatinib Mesylate)https://ClinicalTrials.gov/show/NCT00354523
168328168328Topical GW842470X In Adults Patients With Moderate Atopic DermatitisCompletedNo Results AvailableAtopic Dermatitis|Dermatitis, AtopicDrug: GW842470X creamhttps://ClinicalTrials.gov/show/NCT00354510
168329168329Prostate Cancer Screening and Dietary Heterocyclic Amines in African American MenRecruitingNo Results AvailableProstate CancerOther: physiologic testing|Other: study of socioeconomic and demographic variables|Procedure: evaluation of cancer risk factors|Procedure: mutation carrier screening|Procedure: study of high risk factorshttps://ClinicalTrials.gov/show/NCT00354497
168330168330Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum PatientsCompletedHas ResultsPostpartum AnemiaDrug: Ferric Carboxymaltose (FCM)|Drug: Ferrous Sulfate tabletshttps://ClinicalTrials.gov/show/NCT00354484

* Görseller ve İçerik tekif hakkına sahip olabilir